Ophthalmologist and refractive eye surgeon Dr Ben LaHood is giving the RayOne Galaxy IOL the thumbs up after being one of the first in Australia to use the lens.
Launched at the European Society of Cataract and Refractive Surgeons Congress in Barcelona in September, the RayOne Galaxy IOL comes to market 75 years after Rayner pioneered the first IOL with Sir Harold Ridley, a milestone being celebrated throughout 2024.
The latest version is described as the world’s first spiral intraocular lens designed with artificial intelligence (AI).
Clinical investigations with RayOne Galaxy began earlier in 2024 with eight leading surgeons globally, as well as key research labs in Europe and Brazil.
Adelaide surgeon Dr LaHood has used the lens in cataract surgery and described it as a “game-changer”.
“It has allowed me to provide a full range of focus to my patient without the optical side effects of a trifocal IOL,” he said.
“This feels like the next evolutionary step in IOL technology.”
The British company said RayOne Galaxy featured a “revolutionary spiral optic that progressively elongates focus, creating a smooth and continuous variation in optical power along the defocus curve”.
“The result is a full range of vision without the wave-like defocus pattern seen with trifocal IOLs.*
It said patients experienced significantly less halo and glare than with diffractive lenses, and the unique non-diffractive spiral structure avoids abrupt transitions in the lens’ surface, which are known to increase dysphotopsia and light loss.
The RayOne Galaxy IOL uses the same fully preloaded injector as the rest of the RayOne IOL family.
“With over five million in use worldwide, the single-use RayOne injector is simple to prepare and use, reducing training for clinic teams and supporting surgeon confidence in the operating room.
“When patient satisfaction is non-negotiable, the RayOne Galaxy is a new premium lens solution designed to eliminate dysphotopic compromise.”
Prostheses List reimbursement approval is pending for the RayOne Galaxy, so it is currently only available for self-funded patients.
People seeking more information were encouraged to visit Rayner.com/Galaxy.
More reading
New Rayner RayOne Galaxy ‘world’s first spiral IOL’
Rayner re-launches Sophi Phaco system in Australian market
Could our spiral lens revolutionise optics? – Laurent Galinier
